Pfizer Inc.‘s ousted CEO Jeffrey Kindler will receive about $9.6 million in severance, bonus, and short term incentive pay for 2010, according to a severance package made public late Thursday.

Kindler, who was promoted from general counsel to chairman and chief executive officer of the drug giant four years ago, also is entitled to retirement pay, stock holdings, and other benefits. The severance package, agreed to only hours before Pfizer’s board of directors met last Sunday and accepted Kindler’s resignation, was surprisingly small.